UBS Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-464,483
Closed -$37.1M 9054
2021
Q1
$37.1M Buy
464,483
+404,913
+680% +$32.3M 0.01% 758
2020
Q4
$4.7M Buy
59,570
+239
+0.4% +$18.8K ﹤0.01% 1895
2020
Q3
$2.61M Buy
59,331
+9,645
+19% +$424K ﹤0.01% 2204
2020
Q2
$2.2M Sell
49,686
-32,511
-40% -$1.44M ﹤0.01% 2203
2020
Q1
$2.95M Buy
82,197
+13,381
+19% +$480K ﹤0.01% 1872
2019
Q4
$4.88M Buy
68,816
+6,230
+10% +$442K ﹤0.01% 2013
2019
Q3
$4.68M Sell
62,586
-6,520
-9% -$488K ﹤0.01% 1901
2019
Q2
$5.57M Sell
69,106
-6,000
-8% -$484K ﹤0.01% 1741
2019
Q1
$5.02M Buy
75,106
+4,546
+6% +$304K ﹤0.01% 1765
2018
Q4
$5.25M Sell
70,560
-18,881
-21% -$1.41M ﹤0.01% 1660
2018
Q3
$8.23M Buy
89,441
+16,414
+22% +$1.51M ﹤0.01% 1537
2018
Q2
$7.18M Buy
73,027
+5,692
+8% +$560K ﹤0.01% 1597
2018
Q1
$7.5M Buy
67,335
+3,081
+5% +$343K ﹤0.01% 1550
2017
Q4
$6.61M Buy
64,254
+4,834
+8% +$497K ﹤0.01% 1623
2017
Q3
$5.6M Buy
59,420
+7,211
+14% +$679K ﹤0.01% 1652
2017
Q2
$4.07M Sell
52,209
-42,212
-45% -$3.29M ﹤0.01% 1849
2017
Q1
$7.56M Sell
94,421
-3,833
-4% -$307K ﹤0.01% 1357
2016
Q4
$7.74M Buy
98,254
+5,279
+6% +$416K ﹤0.01% 1282
2016
Q3
$7.25M Buy
92,975
+46,919
+102% +$3.66M ﹤0.01% 1283
2016
Q2
$3.17M Sell
46,056
-6,574
-12% -$452K ﹤0.01% 1860
2016
Q1
$3.76M Buy
52,630
+1,348
+3% +$96.2K ﹤0.01% 1668
2015
Q4
$3.19M Sell
51,282
-33
-0.1% -$2.05K ﹤0.01% 1844
2015
Q3
$2.91M Sell
51,315
-14,135
-22% -$801K ﹤0.01% 1881
2015
Q2
$3.51M Buy
65,450
+7,207
+12% +$387K ﹤0.01% 1879
2015
Q1
$2.77M Buy
58,243
+5,162
+10% +$245K ﹤0.01% 2046
2014
Q4
$2.3M Buy
+53,081
New +$2.3M ﹤0.01% 2140